Biorestorative Therapies, Inc. current report, 04 October 2013

Biorestorative Therapies, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Form 8-K reports on the Annual Meeting of Shareholders held by Biorestorative Therapies, Inc. on October 4, 2013. The filing details the voting results for director elections, executive compensation, and the ratification of the independent auditor.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.

Material Changes and Voting Results

Shareholders approved all matters presented at the Annual Meeting:

  • Election of Directors: All three nominees (Mark Weinreb, A. Jeffrey Radov, and Joel San Antonio) were elected. Significant broker non-votes (1,766,923 shares) were recorded for each nominee.
  • Executive Compensation: The advisory vote on executive compensation was approved with 6,863,712 votes for and 88,620 against.
  • Compensation Vote Frequency: Shareholders recommended future advisory votes be held every three years (5,672,375 votes), compared to one year (770,948 votes) or two years (549,378 votes).
  • Auditor Ratification: Marcum LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2013, with 8,731,668 votes for and 10,928 against.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for future guidance, management commentary on business outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of shareholder vote tallies.

Investor Verification Checklist

  • Verify the total number of shares outstanding to contextualize the broker non-vote count of 1,766,923.
  • Confirm the specific terms of the executive compensation package approved by shareholders.
  • Review the full Annual Report (Form 10-K) for the fiscal year ended December 31, 2012, to obtain financial performance data not included in this 8-K.
  • Check subsequent filings for any changes to the Board of Directors or auditor selection.